Screener
Relay Therapeutics, Inc. RLAY Other Income Expense
Other Income Expense at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlay:OtherIncomeExpense.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (90,824) | (76,847) | (169,414) | (161,717) |
| Other income: | ||||
| Interest income | 7,115 | 7,105 | 12,467 | 14,918 |
| Other income (expense) | 2 | (633) | (51) | (641) |
| Total other income, net | 7,117 | 6,472 | 12,416 | 14,277 |
| Net loss | $(83,707) | $(70,375) | $(156,998) | $(147,440) |
| Net loss per share, basic and diluted | $(0.41) | $(0.41) | $(0.82) | $(0.87) |
| Weighted average shares of common stock, basic and diluted | 202,849,466 | 171,264,622 | 191,412,839 | 170,254,500 |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s other income expense?
- Relay Therapeutics, Inc. (RLAY) reported other income expense of $2K in Q2 2026.
- How has Relay Therapeutics, Inc.'s other income expense changed year-over-year?
- Relay Therapeutics, Inc.'s other income expense increased by 100.3% year-over-year, from -$633K to $2K.
- What is the long-term trend for Relay Therapeutics, Inc.'s other income expense?
- Over 3 years (2022 to 2025), Relay Therapeutics, Inc.'s other income expense has grown at a 243.0% compound annual growth rate (CAGR), from -$20K to -$807K.
- What does other income expense mean?
- Other Income Expense as reported by Relay Therapeutics, Inc. Common Stock.
Ask your AI about Relay Therapeutics, Inc.'s other income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude